Stock CATX PERSPECTIVE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Perspective Therapeutics, Inc.

Equities

CATX

US46489V1044

Market Closed - Nyse
Other stock markets
 04:00:03 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.4 USD +6.06% Intraday chart for Perspective Therapeutics, Inc. -6.67% +248.26%
May. 24 Perspective Therapeutics Prices $80 Million Share, Warrant Offering MT
May. 15 Transcript : Perspective Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:00 AM

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
RBC Starts Perspective Therapeutics With Outperform Rating, $3 Price Target
MT
Cantor Fitzgerald Starts Perspective Therapeutics With Overweight Rating
MT
B. Riley Raises Price Target on Perspective Therapeutics to $1.70 From $1.20, Maintains Buy Rating
MT
Oppenheimer Adjusts Perspective Therapeutics Price Target to $1.50 From $1.20, Maintains Outperform Rating
MT
B. Riley Starts Perspective Therapeutics With Buy Rating, $1.20 Price Target; Says Well-Positioned to Break Out of Biotech Pack
MT
JonesTrading Initiates Perspective Therapeutics With Buy Rating, $1.40 Price Target
MT
Oppenheimer Adjusts Perspective Therapeutics Price Target to $1.20 From $1, Maintains Outperform Rating
MT
ISORAY : Northland Capital Starts IsoRay at Outperform with $1.25 Price Target
MT
ISORAY : Oppenheimer Adjusts IsoRay PT to $1.50 From $1, Maintains Outperform Rating
MT
ISORAY : Oppenheimer Starts IsoRay at Outperform with $1 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CATX Stock
  4. News Perspective Therapeutics, Inc.
  5. Analyst Reco.